Found: 138 articles

Article Edition
M.B. Antsiferov, O.M. Koteshkova
EFFICIENCY OF TRIPLE THERAPY USING LIRAGLUTIDE (VICTOZA) - FIRST LONG-ACTING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST - IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND VISCERAL OBESITY
№5 / 2015
A.S. Ametov
ADVANTAGES OF FIXED COMBINATION OF SAXAGLIPTIN AND METFORMIN WITH MODIFIED RELEASE (KOMBOGLYCE PROLONG) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
№5 / 2015
N.A. Chernikova, L.P. Ivanova, F.T. Abaeva
ADVANTAGES OF TIMELY INITIATION OF INSULIN THERAPY. RESULTS OF THE RUSSIAN OBSERVATIONAL PROGRAM HUBIN
№5 / 2015
A.M. Mkrtumyan
ALOGLIPTIN – EFFECTIVE AND SAFE DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN THE THERAPY OF TYPE 2 DIABETES MELLITUS
№5 / 2015
T.Yu.Demidova
SGLT 2INHIBITORS: PHARMACOLOGICAL GLYCOSURIA AS A NEW APPROACH TO THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
№5 / 2015
M.B. Antsiferov
CLINICAL INERTIA IN THE THERAPY OF TYPE 2 DIABETES MELLITUS
№5 / 2015
O.A. Gromova (1, 2), I.Yu. Torshin (2, 3), O.A. Limanova (1, 2), T.R. Grishina (1), A.N. Gromov (3)
VITAMIN D CONCENTRATIONS AND METABOLIC DISORDERS: SYSTEMATIC ANALYSIS OF THE FUNDAMENTAL AND EVIDENCE-BASED STUDIES ON THE PROBLEM OF OVERWEIGHT AND DIABETES MELLITUS
№20 / 2014
N.V. Zaitseva, M.Sh. Shamkhalova
COMBINATION THERAPY WITH GLIMEPIRIDE AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. THE RESULTS OF OBSERVATIONAL STUDIES
№16 / 2014
E.V.Surkova
EFFICACY AND SAFETY OF BIPHASIC INSULIN ANALOGUE NOVOMIX -30 IN TYPE 2 DIABETES MELLITUS: FROM CLINICAL RESEARCH TO REAL PRACTICE
№16 / 2014
I.V. Glinkina
ORIGIN STUDY (OUTCOME REDUCTION WITH INITIAL GLARGINE INTERVENTION) 2 YEARS LATER: WHAT’S NEW?
№16 / 2014
A.F. Verbovoy, L.A. Sharonova, R.I. Akhmerova
EFFECTS OF SHORT-TERM THERAPY WITH ROSUVASTATIN ON LIPID METABOLISM IN PATIENTS WITH CORONARY ARTERY DISEASE
№16 / 2014
E.V. Biryukova
FIXED COMBINATION OF SAXAGLIPTIN AND METFORMIN WITH MODIFIED RELEASE - NEW STEP IN THE IMPROVEMENT OF TREATMENT COMPLIANCE IN TYPE 2 DIABETES MELLITUS
№16 / 2014


Бионика Медиа